PDF | TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate. | ID: gf06gf611

TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate.

Kabagambe, Edmond K.

Glasser, Stephen P.

Ordovas, Jose M.

Warodomwichit, Daruneewan.

Tsai, Michael Y.

Hopkins, Paul N.

Borecki, Ingrid B.

Wojczynski, Mary.

Arnett, Donna K.

2009

Description

Background: Inflammation is implicated in causing diabetes. We tested whether transcription factor 7 like-2 (TCF7L2) gene polymorphisms (rs12255372 and rs7903146), consistently associated with type 2 diabetes, are associated with plasma concentrations of inflammatory markers before and after three weeks of daily treatment with ... read more

This object is in collection

Permanent URL

Citation

Kabagambe, Edmond, Stephen P. Glasser, Jose M. Ordovas, Daruneewan Warodomwichit, Michael Y. Tsai, Paul N. Hopkins, Ingrid B. Borecki, Mary Wojczynski, and Donna K. Arnett. "TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate." Diabetology & Metabolic Syndrome 1, no. 1 (12, 2009): 1-4.